In particular, the Tumor Presence Signature (TPS) herein described shows an AUC of 0.788 resulting from cumulative ROC curve analysis involving CD2, CD3, CD56 and CD146, thus delineating their common involvement in LCa cancer onset and progression. The gene discussed is CD2; the disease is neoplasm.